A recent study reveals that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide can put back on lost weight far faster than those who stop conventional diet and exercise plans.
Findings released in a prominent health publication demonstrates that while overweight individuals can lose about a fifth of their body weight while undergoing treatment, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals buying such medications must be informed of the risk of rapid weight regain when the treatment concludes," stated researcher Dr. Susan Jebb.
This pace of regain means a reversion to pre-treatment weight within about one and a half years.
Weighing Approaches
The research, which looked at 37 of trials involving thousands of patients, contrasted the effects of the injectable medications with other pills.
The team emphasize that individuals who shed pounds through diet and exercise typically experience a less rapid weight regain—around 100 grams monthly—post-intervention.
Explaining the Fast Rebound
Nutrition scientists suggest the mode of action of the drugs explains the heightened weight return.
These medications copy a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Artificially providing GLP-1 concentrations far above than normal may cause the system to produce less of its own natural GLP-1, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is uncontrolled, making binge eating much more probable."
A Lifelong Disease?
Medical guidelines suggest the jabs for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians say that, given the high risk of weight regain, the therapy should be considered life-long.
This perspective is supported by drug manufacturers, who note that the results "emphasize the chronic character of excess weight," similar to managing conditions like diabetes.
User Experiences
Users who have stopped the jabs report a powerful resurgence of hunger.
"It was like a switch that goes on and I was suddenly extremely hungry," said a patient.
This challenge is worsened if individuals have not established sustainable dietary or behavioural modifications during treatment.
Widespread Interest
Recent estimates suggest that millions of people in the UK have tried these injections in the last 12 months, with desire remaining high.
- Adoption is greater among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private healthcare rather than the NHS.
In conclusion, clinicians stress that while the jabs are effective tools for weight loss, they are not a standalone solution and maintained weight loss hinges on ongoing behavioural support.
